No Detail Found!

Nephroprotective role of eugenol against cisplatin-induced acute kidney injury in mice

Author(s)
Abdul Kadir Faculty of Pharmacy, Ziauddin University,Karachi,Pakistan
Sammie Sher Ziauddin Medical College, Ziauddin University,Karachi,Pakistan
Rehan Ahmed Siddiqui Department of Research, Ziauddin University,Karachi,Pakistan
Talat Mirza Department of Research, Ziauddin University,Karachi,Pakistan
Abstract
Cisplatin (CP) is a choice of drug for cancer chemotherapy. Its nephrotoxic effects are well reported and limit its use. In this study, we aim to assess the nephroprotective potential of eugenol on cisplatin-induced acute kidney injury (AKI). Thirty male, BALB/c mice were randomly divided into five groups. Normal saline was given to controls in normal group (group 1), CP group (group 2) received CP injection (20 mg/kg), and other two groups 3 and 4 were treated with eugenol at doses of 50 and 100 mg/kg respectively for four days before receiving cisplatin. While group 5 (positive control) received ascorbic acid (200 mg/kg) for four days before CP injection. Blood samples were collected after 72 hours of CP injection and kidneys were dissected out. Blood urea and creatinine values were increased significantly (p <0.001) in CP group. However, significant improvement (p <0.001) was seen in eugenol treated groups. Similar pattern was observed in kidney injury score (p <0.001) which markedly improved after eugenol treatment. Improvement in protein cast in tubular lumen and tubular brush borders was also observed. Eugenol has an ameliorative role in AKI induced by cisplatin in mice. This compound is recommended for further evaluation of its mechanism(s) of action.
Publication Details
Page(s) 1281-1287
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP3, Year: 2020

Request the full text from PASTIC

Keywords
Cisplatin, Eugenol, Acute Kidney Injury
References
Arunkumar PA,Viswanatha GL,Radheshyam N,Mukund H,Belliyappa MS H .2012 .Science behind 1286 cisplatin-induced nephrotoxicity in humans: A clinical study. Asian Pac. J. Trop. Biomed., 2(8) : 640.
Barhoma RA .2018 .The role of eugenol in the prevention of chromium-induced acute kidney injury in male albino rats. Alexandria J. Med, 54(4) : 711-715.
Ekinci Akdemir FN,Yildirim S,Kandemir FM,Aksu EH,Guler MC,Kiziltunc Ozmen H,Kucukler S,Eser G .2019 .The antiapoptotic and antioxidant effects of eugenol against cisplatin‐induced testicular damage in the experimental model. Andrologia, 51(9) : e13353.
Garud MS,Kulkarni YA .2017 .Eugenol ameliorates renal damage in streptozotocin-induced diabetic rats. Flavour Frag. J., 32(1) : 54-62.
Giuliani F .2014 .The Composition, Structure, Sources, and Applications of Eugenol. , 12(1) : 19.
Gomez-Ruiz S,Maksimović-Ivanić D,Mijatović S,Kaluđerović GN,Article ID .2012 .On the discovery, biological effects, and use of cisplatin and metallocenes in anticancer chemotherapy. Bioinorg. Chem. Appl., : .
Hagar H,El Medany A,Salam R,El Medany G,Nayal OA G .2015 .Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats. Exp. Toxicol, 67(2) : 133-141.
Karasawa T,Steyger PS .2015 .An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. , 237(3) : 219-227.
Malik S,Bhatia J,Suchal K,Gamad N,Dinda AK,Gupta YK,Arya DS .2015 .Nobiletin ameliorates cisplatin-induced acute kidney injury due to its antioxidant, anti-inflammatory and anti-apoptotic effects. Exp. Toxicol, 67(7-8) : 427-433.
Miller RP,Tadagavadi RK,Reeves WB .2010 .Mechanisms of cisplatin nephrotoxicity. Toxins, 2 : 2490-2518.
Mishra J,Mori K,Ma Q,Kelly C,Barasch J,Devarajan P .2004 .Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity. Am. J. Nephrol., 24(3) : 307-315.
Noori S and Mahboob T .2010 .Antioxidant effect of carnosine pretreatment on cisplatin-induced renal oxidative stress in rats. Ind. J. Clin. Biochem, 25(1) : 86-91.
Oh GS,Kim HJ,Shen A,Lee SB,Khadka D,Pandit A,So HS .2014 .Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrol, 12(2) : 55-65.
Oun R,Moussa YE,Wheate NJ .2018 .The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalton Trans., 47(19) : 6645-6653.
Ozkok A,Edelstein CL .2014 .Pathophysiology of cisplatin-induced acute kidney injury. Biomed. Res. Int., : 1-17.
Özülker F,Özülker T,Uzun AK,Özpaçacı T .2011 .Investigation of the efficacy of 99 mTc-DTPA scintigraphic GFR measurement with Gates method in the detection of cisplatin-induced nephrotoxicity in comparison with plasma urea and creatinine measurement. Med, 28(4) : 1101-1106.
Pabla N and Dong Z .2008 .Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kid. Int., 73(9) : 994-1007.
Fogo Paueksakon P,AB Paueksakon P .2017 .Drug‐induced nephropathies. , 70(1) : 94-108.
Ravindra P,Bhiwgade DA,Kulkarni S,Rataboli PV,Dhume CY .2010 .Cisplatin induced histological changes in renal tissue of rat. J. Cell Anim. Biol, 4(7) : 108-111.
Rybak LP,Whitworth CA,Mukherjea D,Ramkumar V .2007 .Mechanisms of cisplatin-induced ototoxicity and prevention. Hearing Res., 226(1-2) : 157-167.
Said MM .2011 .The protective effect of eugenol against gentamicin‐induced nephrotoxicity and oxidative damage in rat kidney. Fund. Clin. Pharmacol, 25(6) : 708-716.
Saifullah N,Siddiqui RA,Memon Z,Shahid MA,Mirza T .2019 .Eugenol ameliorates rhabdomyolysisinduced acute kidney injury in mice. Pak. J. Med, 8(3) : 25-29.
Siddiqui RA,Simjee SU,Kabir N,Ateeq M,Shah MR,Hussain SS .2019 .N-(2-hydroxyphenyl) acetamide and its gold nanoparticle conjugation prevent glycerol-induced acute kidney injury by attenuating inflammation and oxidative injury in mice. Mol. Cell, 450(1-2) : 43-52.
Sooriyaarachchi M,George GN,Pickering IJ,Narendran A,Gailer J .2016 .Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy. Metajs, 8(11) : 1170-1176.
World Health Organization .2015 .The selection and use of essential medicines: Report of the WHO expert committee, 2015 (including the 19th WHO model list of essential medicines and the 5th WHO model list of essential medicines for children). , 994 : .
Xu Y,Ma H,Shao J,Wu J,Zhou L,Zhang Z,Wang Y,Huang Z,Ren J,Liu S,Chen X .2015 .A role for tubular necroptosis in cisplatin-induced AKI. J. Am. Soc. Nephrol., 26(11) : 2647-2658.
Yogalakshmi B,Viswanathan P,Anuradha CV .2010 .Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. , 268(3) : 204-212.
0

Citations

0

Downloads

13

Views